Accolate and Aerobid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Accolate (zafirlukast) and Aerobid (flunisolide). Common drug interactions include mitral valve incompetence among females and appetite increased among males.

The phase IV clinical study analyzes what interactions people have when they take Accolate and Aerobid. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Accolate?

Accolate has active ingredients of zafirlukast. It is often used in asthma. eHealthMe is studying from 4,220 Accolate users. Check the latest studies of Accolate.

What is Aerobid?

Aerobid has active ingredients of flunisolide. eHealthMe is studying from 1,126 Aerobid users. Check the latest studies of Aerobid.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 27, 2026

44 people who take Accolate and Aerobid together, and have interactions are studied.

Accolate and Aerobid drug interactions.

What are the common drug interactions of Accolate and Aerobid, by gender? *:

female:

  1. Mitral valve incompetence (inefficient heart valve)
  2. Myelitis (infection or the inflammation of white matter or gray matter of spinal cord which is a part of central nervous system)
  3. Neck pain
  4. Necrosis (the death of body tissue)
  5. Nervousness
  6. Otitis externa (external ear infection)
  7. Otitis media (inflammation of the middle ear)
  8. Pain
  9. Pain in limb
  10. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

male:

  1. Appetite increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires)
  2. Blood creatine phosphokinase increased
  3. Appetite decreased (decreased appetite occurs when you have a reduced desire to eat)
  4. Asthenia (weakness)
  5. Balance disorder
  6. Cardiac arrest
  7. Cough
  8. Deafness transitory (deafness temporary)
  9. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  10. Diplopia (double vision)

What are the common drug interactions of Accolate and Aerobid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  2. Pruritus (severe itching of the skin)
  3. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  4. Weight decreased

20-29:

  1. Arrhythmia (irregular heartbeat)
  2. Cardiac arrest
  3. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  4. Drug ineffective
  5. Status asthmaticus (a asthma attack not responds to regular medicines)
  6. Vomiting
  7. Acute respiratory failure
  8. Breath sounds decreased
  9. Cough
  10. Pulmonary congestion (congestion in the lungs)

30-39:

n/a

40-49:

  1. Sjogren's syndrome (a disease that causes dryness in the mouth and eyes)
  2. Syncope (loss of consciousness with an inability to maintain postural tone)
  3. Unevaluable reaction
  4. Wegener's granulomatosis (inflammation of the blood vessels lungs sinuses)
  5. Appetite decreased (decreased appetite occurs when you have a reduced desire to eat)
  6. Appetite increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires)
  7. Blood albumin decreased
  8. Blood alkaline phosphatase nos increased
  9. Blood creatine phosphokinase increased
  10. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)

50-59:

  1. Sweating increased (excess sweating)
  2. Breast pain
  3. Night sweats (sweating in night)
  4. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  5. Back pain
  6. Cardiomegaly (increased size of heart than normal)
  7. Cardiomyopathy (weakening of the heart muscle)
  8. Chest pain
  9. Churg strauss syndrome (infection of small arteries and vein)
  10. Cough

60+:

  1. Alopecia (absence of hair from areas of the body)
  2. Blood creatine phosphokinase increased
  3. Abdominal discomfort
  4. Anaemia (lack of blood)
  5. Appetite increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires)
  6. Arrhythmia (irregular heartbeat)
  7. Asthenia (weakness)
  8. Balance disorder
  9. Blood in stool
  10. Cardiac arrest

* Approximation only. Some reports may have incomplete information.

Do you take Accolate and Aerobid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Accolate and Aerobid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Accolate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Aerobid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Accolate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aerobid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on zafirlukast and flunisolide (the active ingredients of Accolate and Aerobid, respectively), and Accolate and Aerobid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: